Top

memo - Magazine of European Medical Oncology

Published in:

01-06-2019 | editorial

memo—publisher’s report 2018

Author: Dr. Alois Sillaber

Published in: memo - Magazine of European Medical Oncology | Issue 2/2019

Excerpt

All editions of the journal memo—Magazine of European Medical Oncology are accessible and available worldwide via the SpringerLink platform (https://link.springer.com/journal/12254). A look at the last few years of this online presence shows how successful the magazine is in the electronic world. …

Title: memo—publisher’s report 2018
Author: Dr. Alois Sillaber
Publication date: 01-06-2019
Publisher: Springer Vienna
Published in: memo - Magazine of European Medical Oncology / Issue 2/2019
Print ISSN: 1865-5041
Electronic ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-019-0484-7

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2019

Overcoming resistance and bypassing checkpoints—possible new therapeutic frontiers in oncology

Resistance to chemotherapy and anti-angiogenic therapy in ovarian cancer

Direct oral anticoagulants: a treatment option in oncological patients

Lung cancer screening—the surgeon’s perspective

Correction to: Seasonal fever for 11 years! A presentation of hemophagocytic lymphohistiocytosis secondary to marginal zone lymphoma

Educational no.5: next-generation gene panel sequencing

Keynote webinar | Spotlight on antibody–drug conjugates in cancer